跳至主要内容
临床试验/NCT06740942
NCT06740942招募中不适用

Imaging and Serological Biomarkers of Autonomic Dysfunction After Ischemic Stroke

Universitätsklinikum Hamburg-Eppendorf1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年8月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Autonomic dysfunction

研究概览

简要总结

The goal of this observational study is to

  • to investigate the prevalence and time course of autonomic dysfunction in acute ischemic stroke patients;
  • to evaluate the influence of lesion location on autonomic dysfunction;
  • to identify patterns of structural and functional brain connectivity within the central autonomic control circuits associated with autonomic dysfunction; and
  • to explore causal models of the link between brain lesions; cardiac, immunological and endocrine biomarkers; and dysautonomia.

Researchers will compare patients with acute ischemic stroke to patients with transient ischemic attacks to study the effect of acute ischemic brain lesions.

Participants will

  • undergo cardiovascular autonomic function testing;
  • receive structural and functional MR imaging;
  • provide blood samples for determinaton of serological biomarkers auf dysautonomia.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of either
  • acute ischemic stroke with either an ischemic lesion visible on CT/MRI or persistent focal deficits 24 hours after symptom onset, or
  • Transient ischemic attack with transient clinical deficits including motor or speech disturbance and not restricted to isolated vertigo/dizziness, visual disturbance, or sensory disturbance.
  • symptom onset within 72h prior to hospital admission,
  • a pre-stroke/TIA ability to walk without help from another person (modified Rankin scale score < 4),
  • age > 18 years, and
  • informed consent by either the patient or a legal representative (including a spouse)

排除标准

  • In-hospital stroke,
  • contraindications to MR imaging (e.g., claustrophobia, pregnancy, pacemakers, implants),
  • known moderate to severe dementia,
  • previous structural brain damage (except leukoariosis due to cerebral small vessel disease),
  • hemodynamically relevant stenosis of the common or internal carotid artery, or
  • left heart failure with estimated left ventricular ejection fraction < 50%,
  • concomitant systemic illness that can lead to dysautonomia, such as an active infection, thyroid disease, or neurodegenerative disorder (e.g. PD, MSA).

结局指标

主要结局

Autonomic dysfunction

时间窗: 3-5 days after stroke onset

Cardiovagal and Adrenergic Scores on the Composite Autonomic Scoring Scale (0-7, higher values indicate greater dysfunction)

次要结局

  • Autonomic dysfunction(90 days after stroke onset)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eckhard Schlemm

Principal Investigator

Universitätsklinikum Hamburg-Eppendorf

研究点 (1)

Loading locations...

相似试验